Sanofi (SNY) Stock Forecast
SNY analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 3.91 / 5 from 11 analysts
- Price target
- $53.61 average of analyst targets
- Upside to target
- +32.0% from the latest close
- Next earnings
- October 30, 2026 EPS estimate $1.63
- 52-week range
- $39.12 – $52.34
SNY analyst ratings
11 analystsNumber of analysts at each rating.
SNY price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
SNY earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.51 | $1.49 | $1.53 | $1.69 | −10.8% | 2 |
| Current fiscal year (2026) | $4.93 | $4.84 | $5.15 | $4.67 | +5.6% | 6 |
| Next fiscal year (2027) | $5.28 | $5.02 | $5.55 | $4.93 | +7.1% | 6 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
SNY revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $13.27B | $12.87B | $14.03B | +6.7% | 7 |
| Current fiscal year (2026) | $47.40B | $43.35B | $48.45B | +8.6% | 14 |
| Next fiscal year (2027) | $50.49B | $46.59B | $52.22B | +6.5% | 13 |
SNY EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
SNY revenue: reported and forecast
SNY EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.60 | $1.54 | $1.56 | $1.56 | $1.51 | −5.3% | 0 up · 2 down |
| Current fiscal year (2026) | $4.79 | $4.93 | $5.02 | $5.02 | $4.93 | +3.0% | 0 up · 4 down |
| Next fiscal year (2027) | $5.14 | $5.33 | $5.42 | $5.40 | $5.28 | +2.8% | 0 up · 4 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
SNY earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; SNY beat in 8 of 12.
What analysts expect from SNY
11 analysts cover Sanofi; their consensus rating is buy (3.91 on a 1–5 scale, where 5 is a strong buy). The average price target is $53.61, 32.0% above the latest close of $40.61. Analysts expect earnings of $4.93 per share for 2026, +5.6% from a year earlier. For 2027 the average estimate is $5.28 per share on revenue of $50.5 billion. Sanofi beat the EPS estimate in 8 of the last 12 quarters.
Related: SNY income statement, SNY key metrics, SNY chart. See the SNY stock overview for the latest quote and news.
SNY forecast FAQ
What is Sanofi's price target?
The average analyst price target for Sanofi is $53.61, 32.0% above the latest close of $40.61.
Is Sanofi a buy, hold or sell?
Of 11 analysts covering Sanofi, 5 rate it a strong buy, 0 a buy, 6 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Sanofi's EPS forecast?
Analysts forecast $4.93 per share for 2026 (range $4.84 to $5.15); for 2027 the estimate is $5.28.
What is Sanofi's revenue forecast?
The average revenue estimate for 2026 is $47.4 billion, growth of 8.6%; for 2027 it is $50.5 billion.
When does Sanofi report earnings?
Sanofi is expected to report results for the quarter ending September 30, 2026 on October 30, 2026 before the market opens; the EPS estimate is $1.63.
Does Sanofi usually beat earnings estimates?
Sanofi reported EPS at or above the analyst estimate in 8 of the last 12 quarters.